A STUDY TO EVALUATE A PANEL OF BLOOD BIOMARKERS FOR USE IN PATIENTS UNDERGOING EVALUATION FOR LUNG CANCER, ONC-LN-04

  • STATUS
    Recruiting
  • sponsor
    OncoCyte Corporation
Updated on 23 November 2020

Summary

A STUDY TO EVALUATE A PANEL OF BLOOD BIOMARKERS FOR USE IN PATIENTS UNDERGOING EVALUATION FOR LUNG CANCER, ONC-LN-04

Description

Experimental tests, such as those used on the blood collected in this research study are also known as “investigational.” This means the tests have not been approved by the U.S. Food and Drug Administration (FDA).

In this research study, the accuracy of these blood tests will be determined by comparing the results with other tests as determined by your study doctor.

This is not a treatment study. No individual results will be returned to you and no decisions will be made about any further treatment based on the results of the experimental blood tests done on your blood sample in this study. If you are interested in the research study’s outcome, you can request the Sponsor provide you with a copy of the study’s overall results when it is completed.

In total, approximately 2,500 subjects and up to 30 study sites will participate in this research study in the United States.

Details
Condition Lung Cancer
Clinical Study IdentifierTX146413
SponsorOncoCyte Corporation
Last Modified on23 November 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

The purpose of this research study is to evaluate an experimental blood test, known as the ONC-LN-04 Lung Test, for the detection of lung cancer and have been scheduled for an upcoming screening or have scheduled a lung biopsy and may meet the research study requirements
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note